Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 5/2016

10.06.2016 | Gynecologic Oncology

Long-term experiences with genetic consultation in people with hereditary breast and ovarian cancer

verfasst von: Sabine Eismann, Lisa Vetter, Monika Keller, Thomas Bruckner, Michael Golatta, André Hennings, Christoph Domschke, Nicola Dikow, Christof Sohn, Jörg Heil, Sarah Schott

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Advances in genetics and increased public awareness increased the demand for interdisciplinary genetic outpatient consultation (IOGC). Communicating cancer risk is complex, and ideally information transfer should be individualized. Although psychological experiences with genetic testing have been studied in detail, studies on long-term experiences with IOGC and information transfer are lacking. We assessed patients’ understanding and satisfaction with IOGC in families at risk of hereditary breast and ovarian cancer (HBOC) with the aim of informing best clinical practice, improving compliance and informed decision-making.

Methods

Female counselees referred for IOGC between July 1, 2009 and July 1, 2011 were eligible. Data were collected using a 47-item postal questionnaire to assess sociodemographic, psychological, behavioral parameters. Overall satisfaction and personal usefulness of IOGC were assessed with a five-point, and risk perception with a visual analog scale. Data were analyzed using Spearman rank, Wilcoxon U or Chi-squared test.

Results

612 (72 %) of 849 women participated reported being highly satisfied (75 %, n = 430) and declared personal usefulness (73 %, n = 421) on average 3.5 years after IOGC. Women deemed “high risk” assessed their risk of developing BC as significantly higher than non-high-risk counselees (3.2 versus 3.0, p = 0.00484). Risk perception was lower in BRCA1/2 mutation carriers than in women with unclassified variants or no mutation (2.8 versus 3.5 and 3.1, respectively).

Conclusion

Women with an HBOC background have additional needs to achieve long-term satisfaction after IOGC. Prospective studies are required to optimize care for the increasing number of people who seek genetic consultation, particularly as the complexity of genetics knowledge increases.
Literatur
2.
Zurück zum Zitat Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, King MC (1990) Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250(0036-8075 (Print)):1684–1689CrossRefPubMed Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, King MC (1990) Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250(0036-8075 (Print)):1684–1689CrossRefPubMed
4.
Zurück zum Zitat Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, Collins N, Nguyen K, Seal S, Tran T, Averill D (1994) Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265(0036-8075 (Print)):2088–2090CrossRefPubMed Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, Collins N, Nguyen K, Seal S, Tran T, Averill D (1994) Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265(0036-8075 (Print)):2088–2090CrossRefPubMed
5.
Zurück zum Zitat Gadzicki D, Evans DG, Harris H, Julian-Reynier C, Nippert I, Schmidtke J, Tibben A, van Asperen CJ, Schlegelberger B (2011) Genetic testing for familial/hereditary breast cancer—comparison of guidelines and recommendations from the UK, France, the Netherlands and Germany. J Community Genetics 2(1868-310X (Print)):53–69CrossRef Gadzicki D, Evans DG, Harris H, Julian-Reynier C, Nippert I, Schmidtke J, Tibben A, van Asperen CJ, Schlegelberger B (2011) Genetic testing for familial/hereditary breast cancer—comparison of guidelines and recommendations from the UK, France, the Netherlands and Germany. J Community Genetics 2(1868-310X (Print)):53–69CrossRef
7.
Zurück zum Zitat Lanie AD, Jayaratne TE, Sheldon JP, Kardia SL, Anderson ES, Feldbaum M, Petty EM (2004) Exploring the public understanding of basic genetic concepts. J Genet Couns 13(4):305–320CrossRefPubMedPubMedCentral Lanie AD, Jayaratne TE, Sheldon JP, Kardia SL, Anderson ES, Feldbaum M, Petty EM (2004) Exploring the public understanding of basic genetic concepts. J Genet Couns 13(4):305–320CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Jonassaint CR, Santos ER, Glover CM, Payne PW, Fasaye G-A, Oji-Njideka N, Hooker S, Hernandez W, Foster MW, Kittles RA, Royal CD (2010) Regional differences in awareness and attitudes regarding genetic testing for disease risk and ancestry. Hum Genet 128(3):249–260. doi:10.1007/s00439-010-0845-0 CrossRefPubMedPubMedCentral Jonassaint CR, Santos ER, Glover CM, Payne PW, Fasaye G-A, Oji-Njideka N, Hooker S, Hernandez W, Foster MW, Kittles RA, Royal CD (2010) Regional differences in awareness and attitudes regarding genetic testing for disease risk and ancestry. Hum Genet 128(3):249–260. doi:10.​1007/​s00439-010-0845-0 CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Lynch HT, Watson P, Tinley S, Snyder C, Durham C, Lynch J, Kirnarsky Y, Serova O, Lenoir G, Lerman C, Narod SA (1999) An update on DNA-based BRCA1/BRCA2 genetic counseling in hereditary breast cancer. Cancer Genet Cytogenet 109(2):91–98CrossRefPubMed Lynch HT, Watson P, Tinley S, Snyder C, Durham C, Lynch J, Kirnarsky Y, Serova O, Lenoir G, Lerman C, Narod SA (1999) An update on DNA-based BRCA1/BRCA2 genetic counseling in hereditary breast cancer. Cancer Genet Cytogenet 109(2):91–98CrossRefPubMed
11.
Zurück zum Zitat Metcalfe KA, Liede A, Hoodfar E, Scott A, Foulkes WD, Narod SA (2000) An evaluation of needs of female BRCA1 and BRCA2 carriers undergoing genetic counselling. J Med Genet 37(11):866–874CrossRefPubMedPubMedCentral Metcalfe KA, Liede A, Hoodfar E, Scott A, Foulkes WD, Narod SA (2000) An evaluation of needs of female BRCA1 and BRCA2 carriers undergoing genetic counselling. J Med Genet 37(11):866–874CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Brain K, Gray J, Norman P, Parsons E, Clarke A, Rogers C, Mansel R, Harper P (2000) Why do women attend familial breast cancer clinics? J Med Genet 37(3):197–202CrossRefPubMedPubMedCentral Brain K, Gray J, Norman P, Parsons E, Clarke A, Rogers C, Mansel R, Harper P (2000) Why do women attend familial breast cancer clinics? J Med Genet 37(3):197–202CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Henneman L, Timmermans DR, van der Wal G (2004) Public experiences, knowledge and expectations about medical genetics and the use of genetic information. Community Genet 7(1):33–43. doi:10.1159/000080302 PubMed Henneman L, Timmermans DR, van der Wal G (2004) Public experiences, knowledge and expectations about medical genetics and the use of genetic information. Community Genet 7(1):33–43. doi:10.​1159/​000080302 PubMed
14.
Zurück zum Zitat Lodder L, Frets PG, Trijsburg RW, Meijers-Heijboer EJ, Klijn JG, Duivenvoorden HJ, Tibben A, Wagner A, van der Meer CA, van den Ouweland AM, Niermeijer MF (2001) Psychological impact of receiving a BRCA1/BRCA2 test result. Am J Med Genet 98(1):15–24CrossRefPubMed Lodder L, Frets PG, Trijsburg RW, Meijers-Heijboer EJ, Klijn JG, Duivenvoorden HJ, Tibben A, Wagner A, van der Meer CA, van den Ouweland AM, Niermeijer MF (2001) Psychological impact of receiving a BRCA1/BRCA2 test result. Am J Med Genet 98(1):15–24CrossRefPubMed
16.
Zurück zum Zitat Vetter L, Keller M, Bruckner T, Golatta M, Eismann S, Evers C, Dikow N, Sohn C, Heil J, Schott S (2016) Adherence to the breast cancer surveillance program for women at risk for familial breast and ovarian cancer versus overscreening: a monocenter study in Germany. Breast Cancer Res Treat. doi:10.1007/s10549-016-3748-5 PubMed Vetter L, Keller M, Bruckner T, Golatta M, Eismann S, Evers C, Dikow N, Sohn C, Heil J, Schott S (2016) Adherence to the breast cancer surveillance program for women at risk for familial breast and ovarian cancer versus overscreening: a monocenter study in Germany. Breast Cancer Res Treat. doi:10.​1007/​s10549-016-3748-5 PubMed
18.
Zurück zum Zitat Buchanan AH, Datta SK, Skinner CS, Hollowell GP, Beresford HF, Freeland T, Rogers B, Boling J, Marcom PK, Adams MB (2015) Randomized trial of telegenetics vs. in-person cancer genetic counseling: cost, patient satisfaction and attendance. J Genet Couns 24(6):961–970. doi:10.1007/s10897-015-9836-6 CrossRefPubMed Buchanan AH, Datta SK, Skinner CS, Hollowell GP, Beresford HF, Freeland T, Rogers B, Boling J, Marcom PK, Adams MB (2015) Randomized trial of telegenetics vs. in-person cancer genetic counseling: cost, patient satisfaction and attendance. J Genet Couns 24(6):961–970. doi:10.​1007/​s10897-015-9836-6 CrossRefPubMed
19.
Zurück zum Zitat Kinney AY, Butler KM, Schwartz MD, Mandelblatt JS, Boucher KM, Pappas LM, Gammon A, Kohlmann W, Edwards SL, Stroup AM, Buys SS, Flores KG, Campo RA (2014) Expanding access to BRCA1/2 genetic counseling with telephone delivery: a cluster randomized trial. J Natl Cancer Inst 106(12):dju328. doi:10.1093/jnci/dju328 CrossRefPubMedPubMedCentral Kinney AY, Butler KM, Schwartz MD, Mandelblatt JS, Boucher KM, Pappas LM, Gammon A, Kohlmann W, Edwards SL, Stroup AM, Buys SS, Flores KG, Campo RA (2014) Expanding access to BRCA1/2 genetic counseling with telephone delivery: a cluster randomized trial. J Natl Cancer Inst 106(12):dju328. doi:10.​1093/​jnci/​dju328 CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Schwartz MD, Valdimarsdottir HB, Peshkin BN, Mandelblatt J, Nusbaum R, Huang AT, Chang Y, Graves K, Isaacs C, Wood M, McKinnon W, Garber J, McCormick S, Kinney AY, Luta G, Kelleher S, Leventhal KG, Vegella P, Tong A, King L (2014) Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer. J Clin Oncol 32(7):618–626. doi:10.1200/JCO.2013.51.3226 CrossRefPubMedPubMedCentral Schwartz MD, Valdimarsdottir HB, Peshkin BN, Mandelblatt J, Nusbaum R, Huang AT, Chang Y, Graves K, Isaacs C, Wood M, McKinnon W, Garber J, McCormick S, Kinney AY, Luta G, Kelleher S, Leventhal KG, Vegella P, Tong A, King L (2014) Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer. J Clin Oncol 32(7):618–626. doi:10.​1200/​JCO.​2013.​51.​3226 CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat O’Shea R, Meany M, Carroll C, Cody N, Healy D, Green A, Lynch SA (2015) Predictive genetic testing and alternatives to face to face results disclosure: a retrospective review of patients preference for alternative modes of BRCA 1 and 2 results disclosure in the Republic of Ireland. J Genet Couns. doi:10.1007/s10897-015-9887-8 PubMed O’Shea R, Meany M, Carroll C, Cody N, Healy D, Green A, Lynch SA (2015) Predictive genetic testing and alternatives to face to face results disclosure: a retrospective review of patients preference for alternative modes of BRCA 1 and 2 results disclosure in the Republic of Ireland. J Genet Couns. doi:10.​1007/​s10897-015-9887-8 PubMed
23.
Zurück zum Zitat Albada A, van Dulmen S, Dijkstra H, Wieffer I, Witkamp A, Ausems MG (2015) Counselees’ expressed level of understanding of the risk estimate and surveillance recommendation are not associated with breast cancer surveillance adherence. J Genet Couns. doi:10.1007/s10897-015-9869-x PubMedPubMedCentral Albada A, van Dulmen S, Dijkstra H, Wieffer I, Witkamp A, Ausems MG (2015) Counselees’ expressed level of understanding of the risk estimate and surveillance recommendation are not associated with breast cancer surveillance adherence. J Genet Couns. doi:10.​1007/​s10897-015-9869-x PubMedPubMedCentral
24.
Zurück zum Zitat Butow PN, Lobb EA, Meiser B, Barratt A, Tucker KM (2003) Psychological outcomes and risk perception after genetic testing and counselling in breast cancer: a systematic review. Med J Aust 178(2):77–81PubMed Butow PN, Lobb EA, Meiser B, Barratt A, Tucker KM (2003) Psychological outcomes and risk perception after genetic testing and counselling in breast cancer: a systematic review. Med J Aust 178(2):77–81PubMed
25.
Zurück zum Zitat Sie AS, van Zelst-Stams WA, Spruijt L, Mensenkamp AR, Ligtenberg MJ, Brunner HG, Prins JB, Hoogerbrugge N (2014) More breast cancer patients prefer BRCA-mutation testing without prior face-to-face genetic counseling. Fam Cancer 13(2):143–151. doi:10.1007/s10689-013-9686-z PubMed Sie AS, van Zelst-Stams WA, Spruijt L, Mensenkamp AR, Ligtenberg MJ, Brunner HG, Prins JB, Hoogerbrugge N (2014) More breast cancer patients prefer BRCA-mutation testing without prior face-to-face genetic counseling. Fam Cancer 13(2):143–151. doi:10.​1007/​s10689-013-9686-z PubMed
26.
Zurück zum Zitat Smit AK, Keogh LA, Hersch J, Newson AJ, Butow P, Williams G, Cust AE (2015) Public preferences for communicating personal genomic risk information: a focus group study. Health Expect. doi:10.1111/hex.12406 PubMed Smit AK, Keogh LA, Hersch J, Newson AJ, Butow P, Williams G, Cust AE (2015) Public preferences for communicating personal genomic risk information: a focus group study. Health Expect. doi:10.​1111/​hex.​12406 PubMed
27.
Zurück zum Zitat Audrain J, Rimer B, Cella D, Garber J, Peshkin BN, Ellis J, Schildkraut J, Stefanek M, Vogel V, Lerman C (1998) Genetic counseling and testing for breast-ovarian cancer susceptibility: what do women want? J Clin Oncol 16(1):133–138PubMed Audrain J, Rimer B, Cella D, Garber J, Peshkin BN, Ellis J, Schildkraut J, Stefanek M, Vogel V, Lerman C (1998) Genetic counseling and testing for breast-ovarian cancer susceptibility: what do women want? J Clin Oncol 16(1):133–138PubMed
28.
Zurück zum Zitat Evans DG, Blair V, Greenhalgh R, Hopwood P, Howell A (1994) The impact of genetic counselling on risk perception in women with a family history of breast cancer. Br J Cancer 70(5):934–938CrossRefPubMedPubMedCentral Evans DG, Blair V, Greenhalgh R, Hopwood P, Howell A (1994) The impact of genetic counselling on risk perception in women with a family history of breast cancer. Br J Cancer 70(5):934–938CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Fehniger J, Livaudais-Toman J, Karliner L, Kerlikowske K, Tice JA, Quinn J, Ozanne E, Kaplan CP (2014) Perceived versus objective breast cancer risk in diverse women. J Womens Health (Larchmt) 23(5):420–427. doi:10.1089/jwh.2013.4516 CrossRef Fehniger J, Livaudais-Toman J, Karliner L, Kerlikowske K, Tice JA, Quinn J, Ozanne E, Kaplan CP (2014) Perceived versus objective breast cancer risk in diverse women. J Womens Health (Larchmt) 23(5):420–427. doi:10.​1089/​jwh.​2013.​4516 CrossRef
33.
Zurück zum Zitat Hauke J, Engel C, Wappenschmidt B, Müller RC, Hahnen E (2015) Classification of variants of unknown significance (VUS) in hereditary breast and ovarian cancer. Med Gen 27(2):211–216. doi:10.1007/s11825-015-0049-z Hauke J, Engel C, Wappenschmidt B, Müller RC, Hahnen E (2015) Classification of variants of unknown significance (VUS) in hereditary breast and ovarian cancer. Med Gen 27(2):211–216. doi:10.​1007/​s11825-015-0049-z
34.
Zurück zum Zitat Peipins LA, McCarty F, Hawkins NA, Rodriguez JL, Scholl LE, Leadbetter S (2015) Cognitive and affective influences on perceived risk of ovarian cancer. Psychooncology 24(3):279–286. doi:10.1002/pon.3593 CrossRefPubMed Peipins LA, McCarty F, Hawkins NA, Rodriguez JL, Scholl LE, Leadbetter S (2015) Cognitive and affective influences on perceived risk of ovarian cancer. Psychooncology 24(3):279–286. doi:10.​1002/​pon.​3593 CrossRefPubMed
35.
Metadaten
Titel
Long-term experiences with genetic consultation in people with hereditary breast and ovarian cancer
verfasst von
Sabine Eismann
Lisa Vetter
Monika Keller
Thomas Bruckner
Michael Golatta
André Hennings
Christoph Domschke
Nicola Dikow
Christof Sohn
Jörg Heil
Sarah Schott
Publikationsdatum
10.06.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 5/2016
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-016-4133-7

Weitere Artikel der Ausgabe 5/2016

Archives of Gynecology and Obstetrics 5/2016 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.